Abbott Diagnostics and its subsidiaries are currently working on the development of 270 products that fall under the In Vitro Diagnostics markets. GlobalData’s report Abbott Diagnostics Medical Device Development provides an overview of the company’s pipeline landscape and offers detailed analysis of its products in development. Buy the report here.
The company’s devices in development are either in the late stage of development or are in an early development stage.
The main research and development focus of Abbott Diagnostics is on cancer, followed by cardiovascular diseases, infectious diseases, hormonal disorders, nutritional and metabolic diseases, nervous system diseases, orthopedic diseases and respiratory tract diseases.
Abbott Diagnostics: Top therapeutic area(s) by pipeline products
For a complete picture of the developmental pipeline for Abbott Diagnostics medical devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.